Publications by authors named "S Satomi-Kobayashi"
Background & Aims: In older patients undergoing cardiac surgery, physical function is a critical determinant of postoperative outcomes. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation has been shown to promote muscle protein anabolism and inhibit catabolism, thereby preventing muscle weakness. However, its efficacy in older patients undergoing cardiac surgery remains unknown.
View Article and Find Full Text PDFBackground: Although neurology department ward rounds are among the most important medical education exercises in Japan, they have several issues. Patients may find it unpleasant to undergo repeated neurological tests, especially when in the presence of several students. Only the front row of students can closely observe the examination findings; moreover, students were prohibited from contacting patients altogether during the COVID-19 pandemic.
View Article and Find Full Text PDFThe 88Annual Scientific Meeting of the Japanese Circulation Society (JCS2024) was held from Friday, March 8to Sunday, March 10in Kobe, Japan. The main theme of this 3-day meeting was "The Future of Cardiology: Challenges in Overcoming Cardiovascular Disease". As COVID-19 has been finally conquered, with revision of its categorization under the Infectious Disease Control Law and relaxation of infection prevention measures, it was once again possible to have face-to-face presentations and lively discussion.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the use of maximum phonation time (MPT) to predict postoperative complications like dysphagia and major cardiovascular events in older patients undergoing cardiac surgery.
- It analyzed data from 442 patients, measuring MPT before surgery and assessing complications afterward, finding a correlation between abnormal MPT and higher rates of dysphagia and major adverse events.
- Results suggest that incorporating MPT in preoperative evaluations could help identify high-risk patients, leading to better management and potentially improved outcomes while reducing healthcare costs.
Elevated circulating homocysteine (Hcy) is a well-known risk factor for cardiovascular diseases (CVDs), including coronary artery disease (CAD) and heart failure (HF). It remains unclear how Hcy and its derivatives relate to left ventricular (LV) diastolic function. The aim of the present study was to investigate the relationship between plasma Hcy-related metabolites and diastolic dysfunction (DD) in patients with heart disease (HD).
View Article and Find Full Text PDF